Pfizer (XSWX:PFE) Deferred Tax: CHF-2,019 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:PFE Pfizer Inc XSWX:PFE
70 GF Score
Price CHF22.24
GF Value CHF21.24
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Pfizer Deferred Tax?

Pfizer XSWX:PFE -1.64% 70 Deferred Tax is CHF-2,019 Mil as of Jun. 2026. GuruFocus rates XSWX:PFE with a GF Score™ of 70/100 and a GF Value™ of CHF21.24 (Fairly Valued). The stock has 8 warning signs investors should review.

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Pfizer's change in deferred tax for the three months ended in Jun. 2026 was CHF-1,055 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2026 was CHF-2,019 Mil.

Pfizer Deferred Tax Historical Data

* Premium members only.

The historical data trend for Pfizer's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Deferred Tax Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,953.85 -3,506.54 -2,976.64 -1,874.14 -1,699.79

Pfizer Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -221.19 -609.02 -345.06 -9.45 -1,055.08
XSWX:PFE
70GF Score
Pfizer Inc XSWX:PFE
Deferred Tax is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-2,019 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Deferred Tax →
What does a Deferred Tax of CHF-2,019 Mil mean?
Pfizer (XSWX:PFE) has a Deferred Tax of CHF-2,019 Mil as of Jun. 2026. Change in Defered Tax is amount of deferred tax assets or liabilities due to temporary differences in financial and tax accounting. View historical data for Pfizer.
Is Pfizer's Deferred Tax too high?
Pfizer's current Deferred Tax is CHF-2,019 Mil. Overall, Pfizer has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Deferred Tax compare to BMY and GILD?
Pfizer's Deferred Tax of CHF-2,019 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Deferred Tax for a Drug Manufacturers company?
A good Deferred Tax depends on the Drug Manufacturers industry context. However, Deferred Tax should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Deferred Tax mean?
A high Deferred Tax can signal that a stock is expensive relative to its fundamentals. Change in Defered Tax is amount of deferred tax assets or liabilities due to temporary differences in financial and tax accounting. View historical data for Pfizer. Pfizer's current Deferred Tax is CHF-2,019 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (XSWX:PFE) is currently considered Fairly Valued. The stock's GF Value™ is CHF21.24, compared to a current price of CHF22.24 — trading 4.7% above its estimated fair value. The current Deferred Tax is CHF-2,019 Mil. Pfizer's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Deferred Tax calculated?
Deferred Tax is calculated from a company's financial statements. For Pfizer (XSWX:PFE), the current Deferred Tax is CHF-2,019 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (XSWX:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be overvalued. The current stock price of CHF22.24 is trading 4.7% above its estimated GF Value™ of CHF21.24. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for XSWX:PFE:

  • Deferred Tax: CHF-2,019 Mil
  • GF Value™: CHF21.24 vs. price of CHF22.24 (4.7% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the XSWX:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
70GF Score

Get the complete analysis for XSWX:PFE

Deferred Tax is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF22.24
Price
CHF21.24
GF Value